enow.com Web Search

  1. Ads

    related to: treatment of gigantism in adults with diabetes mellitus patients
    • About Us

      Get to know who we are

      and the mission we're on.

    • Enroll today

      Custom, remote care

      Supplies right to your door

Search results

  1. Results from the WOW.Com Content Network
  2. Acromegaly - Wikipedia

    en.wikipedia.org/wiki/Acromegaly

    Diabetes mellitus [13] ... be injected every 2 to 4 weeks for effective treatment. Most people with acromegaly respond to this medication. ... without gigantism ...

  3. Gigantism - Wikipedia

    en.wikipedia.org/wiki/Gigantism

    After treatment with pegvisomant, high growth rates, a feature characteristic of gigantism, can be significantly decreased. [22] Pegvisomant has been seen to be a powerful alternative to other treatments such as somatostatin analogues, a common treatment method for acromegaly, if drug treatment is paired with radiation .

  4. Growth hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone_therapy

    GH treatment usually decreases insulin sensitivity, [24] but some studies showed no evidence for increased diabetes incidence in GH-treated adult hypopituitary patients. [ 25 ] In past it was believed that GH treatment could increase the cancer risk; a large study recently concluded that "With relatively short follow-up, the overall primary ...

  5. Hyperpituitarism - Wikipedia

    en.wikipedia.org/wiki/Hyperpituitarism

    Hyperpituitarism is a condition due to the primary hypersecretion of pituitary hormones; [3] [medical citation needed] it typically results from a pituitary adenoma.In children with hyperpituitarism, disruption of growth regulation is rare, either because of hormone hypersecretion or because of manifestations caused by local compression of the adenoma.

  6. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

    www.aol.com/diabetes-drugs-really-safe-reliable...

    A Novo Nordisk-sponsored 2021 study followed nearly 2,000 adults with a body mass index (BMI) of 30 or more and without diabetes. It looked at 2.4 milligrams of weekly semaglutide versus a placebo ...

  7. Insulin-like growth factor 1 - Wikipedia

    en.wikipedia.org/wiki/Insulin-like_growth_factor_1

    Low IGF-1 levels are shown to increase the risk of developing type 2 diabetes and insulin resistance. [67] On the other hand, a high IGF-1 bioavailability in people with diabetes may delay or prevent diabetes-associated complications, as it improves impaired small blood vessel function. [67] IGF-1 has been characterized as an insulin sensitizer ...

  1. Ads

    related to: treatment of gigantism in adults with diabetes mellitus patients